Cellectis (NASDAQ:CLLS) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the ...
Insmed Incorporated (NASDAQ:INSM) Receives $83.67 Average PT from Analysts
Shares of Insmed Incorporated (NASDAQ:INSM – Get Free Report) have received a consensus recommendation of “Buy” from the sixteen research firms that are currently covering the firm, MarketBeat.com ...
The First Bancshares, Inc. (NASDAQ:FBMS) Receives $37.17 Average Target Price from Analysts
Shares of The First Bancshares, Inc. (NASDAQ:FBMS – Get Free Report) have received an average recommendation of “Moderate Buy” from the four analysts that are presently covering the firm, Marketbeat ...
Strategically Building A $10,000 Dividend Portfolio: Realty Income As Its Core Position
Learn how holding Realty Income as the largest position in your $10,000 dividend portfolio can reduce risk and maximize ...